Ponstan
Ponstan
- In our pharmacy you can buy ponstan without a prescription, with delivery across the United Kingdom; note that in many countries ponstan (mefenamic acid) is prescription‑only, although some Asian markets allow over‑the‑counter sales.
- Ponstan is used for acute mild-to-moderate pain and primary dysmenorrhoea; it is a non‑steroidal anti‑inflammatory drug (a fenamate) that works mainly by inhibiting cyclooxygenase (COX) and reducing prostaglandin synthesis.
- The usual adult/adolescent (≥14 years) dose is 500 mg initially, then 250 mg every 6 hours as needed (maximum duration: up to 1 week for acute pain, 2–3 days for dysmenorrhoea); follow local prescribing information.
- Administration is oral — tablets or capsules (commonly 250 mg and 500 mg) and oral suspension formulations for paediatric use where available.
- Onset of effect is typically within 30–60 minutes after an oral dose.
- Duration of action is generally around 6 hours, which is why dosing is commonly every 6 hours as required.
- Avoid or limit alcohol while taking ponstan because alcohol increases the risk of gastrointestinal irritation, bleeding and may worsen drowsiness.
- The most common side effect is stomach pain/dyspepsia; other frequent reactions include nausea, diarrhoea, headache, dizziness and rash.
- Would you like to try ponstan without a prescription?
Basic Ponstan Information
- INN (International Nonproprietary Name): Mefenamic acid.
- Brand Names Available In United Kingdom: not specified.
- ATC Code: M01AG01.
- Forms & Dosages: Capsules 250 mg; Tablets 250 mg and 500 mg; Oral suspension 50 mg/5 ml and 100 mg/5 ml (Asia).
- Manufacturers In United Kingdom: not specified.
- Registration Status In United Kingdom: not specified.
- OTC / Rx Classification: Prescription-only (Rx) in most jurisdictions, including EU and similar markets.
Latest Research Highlights
What do recent UK and EU studies tell patients and prescribers about mefenamic acid?
Systematic reviews and meta-analyses that include fenamate drugs show clinically meaningful pain reduction compared with placebo for primary dysmenorrhoea.
National pharmacovigilance continues to log gastrointestinal and hypersensitivity reports in Yellow Card style systems across the UK and EU.
EU observational analyses from 2022–2024 emphasise cautious use in older adults and in people with cardiovascular or renal comorbidity.
UK primary care prescribing audits between 2022 and 2024 indicate declining fenamate prescriptions, with prescribers favouring ibuprofen and naproxen on many NHS formularies.
| Study | Design | Outcome | Safety Note |
|---|---|---|---|
| Cochrane-style Meta-Analyses (Fenamates Included) | RCT Meta-analysis | Effective versus placebo for dysmenorrhoea | Increased gastrointestinal upset reported |
| UK Observational Audits (2022–24) | Primary Care Prescribing Data | Reduced fenamate prescriptions; shift to other NSAIDs | Prescribing shifts linked to tolerability and formulary preference |
| EU Observational Safety Reviews | Population Cohort Studies | Highlight risk in older and comorbid patients | Renal and cardiovascular caution advised |
Data highlights from regulatory and product records note the INN as mefenamic acid, usually supplied as 250 mg capsules or tablets and 500 mg in some markets.
The medicine is prescription-only across the UK and EU markets according to product information.
Clinical Effectiveness In The UK
Does mefenamic acid work for period pain and short-term acute pain?
NHS clinical practice finds mefenamic acid provides reliable short-term relief for acute mild-to-moderate pain and for primary dysmenorrhoea when taken at recommended regimens.
Typical regimens used in practice are a 500 mg loading dose followed by 250 mg every six hours as required, and courses are usually limited to a few days for menstrual pain or up to one week for other acute pain.
Patient-reported outcome measures in primary care audits indicate many users experience faster relief from menstrual cramps than with paracetamol.
Comparative tolerance often favours ibuprofen, and many patients prefer switching if dyspepsia or GI upset occurs.
Where other NSAIDs or hormonal options are unsuitable or ineffective, fenamates remain a valid secondary option in line with UK and EU trial syntheses.
Common patient-reported benefits include quicker cramp relief, reduced need for additional analgesia and predictable dosing.
Common challenges reported by patients include stomach discomfort, nausea and occasional drowsiness.
Pharmacists at Boots, LloydsPharmacy and community GP clinics are expected to document indication on the prescription and provide counselling at collection.
Indications And Expanded Uses
When is mefenamic acid licensed to be used and when is it discouraged?
MHRA-aligned indications reflect EU approvals for treatment of acute mild-to-moderate pain and primary dysmenorrhoea.
Branded names such as Ponstel are known historically, but the UK market currently uses generic mefenamic acid products supplied under the INN.
Off‑label uses in NHS or private practice are limited and generally discouraged for chronic pain, long-term osteoarthritis therapy or routine use in children under 14 because of sparse data and safety concerns.
In some gynaecology clinics mefenamic acid is used for dysmenorrhoea when first-line NSAIDs or hormonal treatments are unsuitable or poorly tolerated.
- MHRA‑Approved Indications: Acute mild-to-moderate pain and primary dysmenorrhoea.
- Common Off‑Label Practices: Short-term use in selected gynaecology cases where alternatives have failed.
- Contraindicated Uses: Long-term osteoarthritis maintenance, routine paediatric use <14 years, and peri‑operative CABG pain management.
Local formulary guidance should be checked before prescribing, and GPs should record indication and duration on electronic prescriptions.
Composition And Brand Landscape In The UK
What is inside each tablet or capsule and which brands are encountered?
The active ingredient is mefenamic acid, a fenamate-type NSAID classified under ATC code M01AG01.
The UK market is largely supplied by generics labelled as mefenamic acid or occasionally as Acidum mefenamicum on some EU imports.
| Form | Strength | Typical Pack Size / Where Sold |
|---|---|---|
| Capsules | 250 mg | Community pharmacies (Boots, LloydsPharmacy), generics from EU/India |
| Tablets | 250 mg, 500 mg | Generic suppliers; 500 mg less common in UK |
| Oral Suspension | 50 mg/5 ml, 100 mg/5 ml | Available in some Asian markets; paediatric formulations not commonly used in UK |
Ponstan and Meftal are recognisable brands internationally but the UK supply is predominantly unbranded generics sourced from a mix of EU and Indian manufacturers.
Pharmacies should verify product origin and batch details when dispensing imported generics and ensure labelling aligns with MHRA requirements.
Contraindications And Special Precautions
Who should not take mefenamic acid and what warnings must patients hear?
Absolute contraindications include known hypersensitivity to mefenamic acid, NSAIDs or salicylates, a history of asthma or urticaria after NSAID use, active peptic ulcer or GI bleeding, severe renal or hepatic impairment and peri‑operative CABG pain.
Special precautions apply to older patients, those with hypertension or cardiovascular disease, people on anticoagulants and those with renal or hepatic impairment.
Pregnancy requires caution and avoidance in the third trimester; breastfeeding patients should seek specific advice from prescribers or pharmacists.
Drowsiness and dizziness may occur and patients should be warned about driving or operating machinery if affected.
Alcohol can increase gastrointestinal risk and may worsen sedation, so counsel patients to avoid excessive alcohol while taking the medicine.
- Absolute Contraindications: Allergy to NSAIDs/salicylates, active GI bleeding, severe renal/hepatic disease, asthma with NSAID sensitivity.
- Relative Contraindications: Elderly, uncontrolled hypertension, anticoagulant use, mild-moderate renal or hepatic impairment.
Pharmacists should flag risks, document counselling on NHS electronic records and encourage Yellow Card reporting for suspected adverse reactions.
Dosage Guidelines
What dose should an adult or adolescent take and how long for?
Standard dosing for adults and adolescents aged 14 years and over is a 500 mg initial dose followed by 250 mg every six hours as required.
Maximum recommended course lengths are up to one week for other acute pain and two to three days per menstrual period for dysmenorrhoea.
It is not recommended for children under 14 years due to limited safety data.
| Patient Group | Standard Dose | Maximum Duration / Notes |
|---|---|---|
| Adults / Adolescents ≥14 years | 500 mg initially, then 250 mg every 6 hours as needed | Acute pain up to 1 week; dysmenorrhoea 2–3 days per period |
| Children <14 years | Not recommended | Use alternative paediatric analgesics where indicated |
| Elderly / Renal or Hepatic Impairment | Consider lower dose and monitoring | Contraindicated in severe renal/hepatic impairment |
For prolonged use, baseline liver and renal function should be considered and therapy reviewed regularly.
Pharmacists should confirm indication, advise on missed doses (do not double up) and tell patients to seek immediate care for signs of overdose such as severe drowsiness or reduced urine output.
Interactions Overview
Which medicines raise concern when taken with mefenamic acid?
Like other NSAIDs, mefenamic acid can increase bleeding risk when used with anticoagulants and antiplatelets and can reduce the antihypertensive effect of ACE inhibitors and ARBs.
Additive renal effects are possible when taken with diuretics or other nephrotoxic drugs.
SSRIs and other agents that impair platelet function increase gastrointestinal bleeding risk when combined with NSAIDs.
Pharmacists should screen the electronic prescription and Summary Care Record for concurrent medicines such as warfarin, DOACs, lithium, methotrexate and ciclosporin.
- High-Risk Interactions: Anticoagulants/antiplatelets, SSRIs, ACE inhibitors/ARBs, diuretics, lithium, methotrexate.
- Mechanisms: Platelet inhibition, reduced renal perfusion, altered drug clearance.
Caffeine-containing analgesics and alcohol can worsen GI side effects and should be discussed at the pharmacy counter.
Cultural Perceptions And Patient Habits In The UK
How do UK patients approach mefenamic acid and where do they seek help?
Many people in the UK consult NHS 111 or a community pharmacist first for period pain, and pharmacists are widely trusted for quick, practical advice.
Forums such as Patient.info and Mumsnet commonly show a mix of preference for paracetamol or ibuprofen due to perceived safety, while some users specifically request mefenamic acid when first‑line options are ineffective.
Common patient concerns include effects on fertility, breastfeeding safety and whether the medicine impairs driving.
Pharmacist prompts that help patients include asking about other medicines, allergies, pregnancy plans and history of stomach ulcers.
Regional cost sensitivity affects decisions, with Scotland, Wales and Northern Ireland having different prescription charge arrangements compared with England and this influencing private purchase patterns.
Short example: a patient collecting a Friday evening prescription often asks whether the 500 mg loading dose is safe with a morning commute; the pharmacist should advise on drowsiness and recommend taking with food.
Availability And Pricing Patterns
Where can patients get mefenamic acid and what does it cost?
Mefenamic acid is prescription-only in the UK and is mainly dispensed through community pharmacies such as Boots, LloydsPharmacy and Superdrug, plus MHRA-regulated online pharmacies using electronic prescriptions.
Branded Ponstan is not commonly marketed in the UK and generics are the norm.
| Access Route | Typical Availability | Typical Private Price Range (Estimate) |
|---|---|---|
| NHS Prescription | Available via GP or electronic prescription; prescription charge applies in England | Standard NHS prescription charge unless exempt |
| Private Purchase (Pharmacy / Online) | Available from community pharmacies and online suppliers with prescription | Variable by pack size and supplier; competitive online pricing common |
| Imports | Generics sourced from EU/India; pharmacists verify origin | Depends on supplier and batch |
Scotland, Wales and Northern Ireland do not charge standard prescription fees, which can influence whether patients request private supply in England.
Storage advice for patients is to keep the medicine at 20–25°C and protect it from moisture.
Note on purchase: in this online pharmacy, ponstan is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.
Comparable Medicines And Prescribing Preferences
What are the practical alternatives and why might a clinician choose mefenamic acid?
Common NSAID alternatives on NHS pathways include ibuprofen and naproxen, with diclofenac and ketoprofen used in selected situations.
Paracetamol is an alternative for milder pain and is generally associated with fewer GI effects.
Ibuprofen is often preferred for tolerability and formulary availability, while naproxen provides longer duration analgesia.
Mefenamic acid may be chosen when a patient had a prior good response to a fenamate or when other NSAIDs are unsuitable.
- Pros Of Mefenamic Acid: Effective for dysmenorrhoea in RCT syntheses and sometimes faster onset for cramps.
- Cons: GI side effects, potential renal and CV risks, and less frequent formulary listing than ibuprofen.
NHS GPs normally follow local formulary guidance and specialist gynaecology teams may recommend mefenamic acid selectively.
Pharmacists should compare side-effect profiles with patients and suggest gastroprotection for at-risk individuals when appropriate.
Frequently Asked Questions
Q: Is mefenamic acid available over the counter?
A: No, in the UK it is prescription-only and should be obtained via a GP or an MHRA-regulated pharmacy.
Q: Can I take mefenamic acid for period pain every month?
A: Short courses of two to three days per period are standard; ongoing monthly use should be reviewed by a clinician because of potential GI, renal and cardiovascular risks.
Q: Can I take mefenamic acid with my blood pressure tablets?
A: Some antihypertensives can interact and reduce efficacy; consult the GP or pharmacist who can check the individual medicines and advise monitoring or alternatives.
Q: What if I miss a dose or suspect an overdose?
A: Take a missed dose when remembered unless the next dose is due; do not double up.
If an overdose is suspected, seek urgent medical attention as symptoms can include nausea, vomiting, drowsiness and renal effects.
For immediate concerns patients should consult NHS 111 or their local pharmacy for advice.
Guidelines For Proper Use And Pharmacist Counselling
What should a pharmacist cover when dispensing mefenamic acid?
Confirm the indication and intended duration of therapy before handing out the medicine.
Review medical history focusing on asthma, GI disease, renal, hepatic and cardiovascular conditions.
Screen for interacting medicines such as anticoagulants, ACE inhibitors, diuretics, SSRIs, lithium, methotrexate and ciclosporin.
Advise on the dosing schedule: 500 mg initial dose, then 250 mg every six hours as needed, with recommended maximum durations.
Explain common side effects including stomach pain, nausea and dizziness and the need to stop and seek urgent care for severe abdominal pain or haematemesis.
Recommend taking the medicine with food to reduce dyspepsia and avoiding excessive alcohol while taking it.
Document counselling on NHS pharmacy records and, where possible, add notes to the patient’s NHS app or GP summary.
Signpost to NHS guidance and to the MHRA Yellow Card scheme for reporting adverse drug reactions.
Delivery Across United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | Greater London | 5-7 days |
| Birmingham | West Midlands | 5-7 days |
| Manchester | Greater Manchester | 5-7 days |
| Glasgow | Scotland | 5-7 days |
| Leeds | West Yorkshire | 5-7 days |
| Liverpool | Merseyside | 5-7 days |
| Bristol | South West England | 5-7 days |
| Edinburgh | Scotland | 5-7 days |
| Sheffield | South Yorkshire | 5-7 days |
| Cardiff | Wales | 5-7 days |
| Newcastle | Tyne and Wear | 5-7 days |
| Belfast | Northern Ireland | 5-7 days |
| Southampton | South East England | 5-9 days |
| Norwich | East of England | 5-9 days |
| Plymouth | South West England | 5-9 days |
Final Notes For Patients
This information summarises product information and UK/EU practice rather than replacing individual advice from a healthcare professional.
Mefenamic acid is effective for many people with dysmenorrhoea and short-term acute pain but shares class safety signals with other NSAIDs, including gastrointestinal and renal risks.
Always confirm prescriptions with the GP and ask the dispensing pharmacist for tailored counselling at collection.
Report suspected adverse reactions to the MHRA Yellow Card scheme and consult NHS 111 for urgent concerns outside normal hours.